Literature DB >> 8390961

HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers.

M Conti1, A Agarossi, F Parazzini, M L Muggiasca, A Boschini, E Negri, E Casolati.   

Abstract

The relation between human immunodeficiency virus (HIV), human papilloma virus (HPV) infection, sexual habits, reproductive history, and risk of cervical intraepithelial neoplasia (CIN) has been analyzed in a cross-sectional study conducted since 1986 among female former intravenous drug abusers attending for the first time to the Colposcopic Unit of the Ospedale Luigi Sacco of Milan and women consecutively admitted to the Community for Past Drug Abusers, S. Patrignano, Rimini. A total of 434 subjects entered the study; of those 128 (30%) had a diagnosis of CIN. Compared with HIV-negative subjects, odds ratio (OR) of CIN was 8.0 (95% confidence interval (CI) 4.6-14.1) for HIV-positive ones and the frequency of CIN 2 and 3 was higher in HIV-positive than that in HIV-negative subjects (chi 2(1), trend, 6.67, P 0.01). Compared with women without current HPV infection the OR estimate was 38.0 (95% CI 20.3-71.2) in those with current diagnosis of HPV infection. Considering HIV-positive subjects only, the frequency of CIN increased with stage of HIV infection and was higher in women with lower CD4+ values. Finally, no relation emerged between CIN risk and age, indicators of sexual habits, oral contraceptive use, parity, and history of spontaneous or induced abortions.

Entities:  

Mesh:

Year:  1993        PMID: 8390961     DOI: 10.1006/gyno.1993.1137

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer.

Authors:  B Clarke; R Chetty
Journal:  Mol Pathol       Date:  2002-02

Review 2.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

3.  Polymerase chain reaction-assisted papillomavirus detection in cervicovaginal smears: stratification by clinical risk and cytology reports.

Authors:  C Kühler-Obbarius; K Milde-Langosch; G Helling-Giese; A Salfelder; C Peimann; T Löning
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 4.  Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments.

Authors:  Alex Ferenczy; François Coutlée; Eduardo Franco; Catherine Hankins
Journal:  CMAJ       Date:  2003-09-02       Impact factor: 8.262

5.  Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated.

Authors:  S J Weissenborn; A M Funke; M Hellmich; P Mallmann; P G Fuchs; H J Pfister; U Wieland
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

6.  Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates.

Authors:  Ingrid T Katz; Lisa M Butler; Tamaryn L Crankshaw; Alexi A Wright; Karen Bramhill; Dominick A Leone; Janet Giddy; Sean Mould
Journal:  J Glob Oncol       Date:  2016-05-04

7.  Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings.

Authors:  Mitzie-Ann Davis; Joe R Delaney; Chandni B Patel; Ryan Storgard; Dwayne G Stupack
Journal:  Drug Des Devel Ther       Date:  2016-06-02       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.